AACE 2026: AI moves from hype to reality in diabetes care

• by Matthew Solan

• April 23, 2026

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management.

• by Kathryn Wighton

• May 6, 2026

• 4 min

Prepregnancy Lipids Predict HDP Risk

A large Swedish cohort found cardiometabolic biomarkers measured up to decades before pregnancy were associated with hypertensive disorders — with risk apparent even below standard diagnostic thresholds.

• by Andrea Surnit

• May 5, 2026

• 4 min

Triangulating evidence for cardiometabolic Index: ROC cutoff, spline nonlinearity, and explainable machine learning for CVD high risk

• by Haoran Wang, Zhiwei Huang, Jing Bai, Haiqin Yuan, Qiaotao Xie, Bing He, Li Guo, Li Wu, Dongliang Liu, Guirang Zhao, Jirui Cai, Jin Wang

• May 20, 2026